Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

Aswath Damodaran on Investing in Uncertainty
Aswath Damodaran on Investing in Uncertainty

Aswath Damodaran teaches corporate finance and valuation at the Stern School of Business at New York University. In this podcast, Motley Fool Senior Analyst Matt Argersinger caught up with Damodaran

Is AT&T Stock a Buy Now?
Is AT&T Stock a Buy Now?

There's a lot of uncertainty in the stock market and the U.S. economy right now, and that's probably putting it lightly. As the Trump administration implements new tariffs, businesses and consumers

3 Top Stocks to Buy and Hold for 20 Years
3 Top Stocks to Buy and Hold for 20 Years

As the stock market swings wildly thanks to erratic, unpredictable, and potentially economically damaging tariff policies from the Trump administration, predicting anything in the near term about

EQS-Adhoc: BP p.l.c.: 1Q25 bp Trading Statement Part 1 of 1
EQS-Adhoc: BP p.l.c.: 1Q25 bp Trading Statement Part 1 of 1
EQS-Adhoc: BP p.l.c.: 1Q25 bp Trading Statement Part 1 of 1
Why Summit Therapeutics Rallied Double Digits Today on Another Down day for the Markets
Why Summit Therapeutics Rallied Double Digits Today on Another Down day for the Markets

Shares of lung cancer-focused biotech Summit Therapeutics (NASDAQ: SMMT) rallied 16.6% at its highs of the day before settling into a 10.4% gain on Thursday as of 3:54 p.m. EDT, even though the

1 Safe Stock to Buy as Tariffs Trigger Market Crash
1 Safe Stock to Buy as Tariffs Trigger Market Crash

There's no such thing as a completely "safe" stock, but some stocks are less risky than others. That's particularly true during times of extreme uncertainty and volatility. The major stock indices

This 17.9%-Yielding Fund Has Maintained Its Payment for Over a Decade. Can That Streak Continue in 2025?
This 17.9%-Yielding Fund Has Maintained Its Payment for Over a Decade. Can That Streak Continue in 2025?

The 17.9% yield of the Guggenheim Strategic Opportunities Fund (NYSE: GOF) is enticing, and as you will see shortly, this fund has an excellent record of distributions to investors. Still, the key

2 Stocks That Have More Than Doubled in the Past Year to Buy and Hold for a Decade
2 Stocks That Have More Than Doubled in the Past Year to Buy and Hold for a Decade

Equity markets recently dipped due to concerns of deteriorating macroeconomic conditions, with the latest trigger being President Trump's trade wars. The S&P 500 index's performance over the

EQS-Adhoc: BP p.l.c.: bp chair announces intention to step down; board launches search for successor
EQS-Adhoc: BP p.l.c.: bp chair announces intention to step down; board launches search for successor
EQS-Adhoc: BP p.l.c.: bp chair announces intention to step down; board launches search for successor
3 Growth Stocks That Have Dwarfed Nvidia's Returns Over the Past 12 Months
3 Growth Stocks That Have Dwarfed Nvidia's Returns Over the Past 12 Months

Is the excitement surrounding chipmaker Nvidia fading? As of Monday, shares of the tech giant were down 19% since the start of 2025. Whether that's due to its high valuation, concerns about the

Is AT&T Stock a Buy?
Is AT&T Stock a Buy?

AT&T (NYSE: T) is often considered a slow-growth stock -- the kind of investment people hold for stable returns and dividends rather than market-beating gains. But over the past 12 months, the

Why Biotech Stocks Like Recursion Pharmaceuticals, CRISPR Therapeutics, and Summit Therapeutics Plunged Today
Why Biotech Stocks Like Recursion Pharmaceuticals, CRISPR Therapeutics, and Summit Therapeutics Plunged Today

Shares of biotechnology stocks such as Recursion Pharmaceuticals (NASDAQ: RXRX), Summit Therapeutics (NASDAQ: SMMT), and CRISPR Therapeutics AG (NASDAQ: CRSP) plunged on Monday, down 9.4%, 5.6%, and

Where Will AT&T Stock Be in 1 Year?
Where Will AT&T Stock Be in 1 Year?

AT&T (NYSE: T) shareholders have plenty to celebrate, with the stock up 24% thus far in 2025. The telecommunications giant has presented robust earnings, reinforcing an optimistic long-term outlook

Here's How Many Shares of AT&T You Should Own to Get $1,000 in Yearly Dividends
Here's How Many Shares of AT&T You Should Own to Get $1,000 in Yearly Dividends

Dividend-paying stocks are hard to beat for income. If you're retired, you can use that money for your living expenses, and if you're still far from retirement, you might simply reinvest those

Is AT&T a Buy?
Is AT&T a Buy?

U.S. telecommunications giant AT&T (NYSE: T) has lulled investors to sleep with its poor performance over most of the past decade. But the stock has enjoyed a face-ripping rally over the past year

Why Dogecoin, Shiba Inu, and Sui Are Soaring This Week
Why Dogecoin, Shiba Inu, and Sui Are Soaring This Week

Cryptocurrencies rebounded this week, as the regulatory landscape continued to improve and as investors reacted to ongoing tariff news. President Donald Trump's business ventures also announced

Better Telecom Stock: AT&T vs. T-Mobile
Better Telecom Stock: AT&T vs. T-Mobile

Uncertainty over the future of the U.S. economy has roiled the stock market, causing many stocks to sink. In this environment, telecom stocks present a potential reprieve. Society's dependence on

Why Summit Therapeutics Stock Slipped Today
Why Summit Therapeutics Stock Slipped Today

Summit Therapeutics (NASDAQ: SMMT) stock did better than a lot of other equities during an otherwise forgettable trading session on Wednesday. In contrast to other titles that fell notably, Summit

Why Lumen Technologies Stock Plummeted Today
Why Lumen Technologies Stock Plummeted Today

Lumen (NYSE: LUMN) stock got hit hard in Tuesday's trading. Its share price was down 10% just before market close on news that the company could wind up selling one of its units to AT&T. The stock

3 Important Things to Know About the Strategic Bitcoin Reserve
3 Important Things to Know About the Strategic Bitcoin Reserve

President Trump followed through on a popular campaign promise this month. After laying the groundwork for a strategic reserve of cryptocurrency holdings in earlier commitments, the March 6 signing

Is Summit Therapeutics a Millionaire Maker?
Is Summit Therapeutics a Millionaire Maker?

Multiple paths to immense wealth exist. A few lucky people win the lottery. Some start successful businesses. Others invest in stocks that deliver explosive gains.

Summit Therapeutics (NASDAQ: SMMT)

3 Important Things to Know About the U.S. Digital Asset Stockpile
3 Important Things to Know About the U.S. Digital Asset Stockpile

On March 6, the White House announced the creation of the U.S. Digital Asset Stockpile. The move was highly anticipated by the crypto industry, which initially viewed it as a major step by the Trump

President Trump Is Planning a Crypto Reserve With These 5 Coins. Should You Invest in Them?
President Trump Is Planning a Crypto Reserve With These 5 Coins. Should You Invest in Them?

Earlier this month, U.S. President Donald Trump announced the creation of the Strategic Bitcoin (CRYPTO: BTC) Reserve and the United States Digital Asset Stockpile. The former will hold Bitcoin --

Should Dividend Stock Investors Buy AT&T Stock?
Should Dividend Stock Investors Buy AT&T Stock?

AT&T (NYSE: T) stock offers passive income investors a robust dividend yield and the chance for an increasing stock price.

*Stock prices used were the afternoon prices of March 19, 2025. The video

President Trump Has Been in Office for Less Than 2 Months. Here's What He Could Do for Cryptocurrency Over the Next Year.
President Trump Has Been in Office for Less Than 2 Months. Here's What He Could Do for Cryptocurrency Over the Next Year.

Changes to the crypto market have been happening at warp speed in 2025. We're only two months into the second presidency of Donald Trump, and we've already seen a scaling back of the Security and